The total investment is 10.8 billion yuan! 6 biopharmaceutical projects landed in Cangshan, Fuzhou

"
Pharmaceutical Network Pharmaceutical Engineering" it is learned that Cangshan recently held a biopharmaceutical industry investment promotion and project signing ceremony, Guangdong Orchard Technology Group Co., Ltd., Beijing Zhongfu Times Asset Management Group Co., Ltd., Guangdong Guosheng Medical Technology Co., Ltdand other six biopharmaceutical projects will be expected to sign Cangshan, a total investment of 10.8 billion yuanIn addition, the Sino-Rich Era joint lying with The Oyuan Capital jointly launched the 10 billion fund, will help the development of the biopharmaceutical industry in CangshanCangshan region has the policy advantage of "six areas overlay", the biopharmaceutical industry is the backbone of the development of the key cangshan, biopharmaceutical industry enterprises in the jurisdiction accounted for 40% of the city, 2019 output value accounted for more than 30% of the city's output valueIn recent years, Cangshan has issued five measures to promote the development of the biopharmaceutical industry, giving enterprises no more than 1.5 million yuan in incentives in terms of research and development costs, scientific research and innovation projects, and one-time evaluation of generic drugsSo far in 2019, a total of more than 220 million yuan of various types of support funds have been cashed, the district also issued the "Biopharmaceutical Industry Promotion Work Programme", through the construction of a biopharmaceutical industry park, the formation of a biopharmaceutical industry alliance, the establishment of a biopharmaceutical industry development guidance fund, the introduction of a biopharmaceutical industry support policy, and gradually build a production, research and development and service integration of the modern urban biopharmaceutical industryin addition, Cangshan held a virtual meeting of biopharmaceutical industry in early April, on the preparation of the "nine measures to promote the high-quality development of the biopharmaceutical industry", to enterprise representatives, university representatives and other participants to seek advice, officially sounded the horn of The high-quality development of the biopharmaceutical industrythe signing of this project is a microcosm of the accelerated development of the biopharmaceutical industry in CangshanSince this year, Cangshan through the industrial chain investment, initiative to go out to attract business and other initiatives, has planned to land in Fujian Province Precision and Regenerative Medicine Engineering Research Center and other 16 bio-pharmaceutical industry projects, and strive to make Cangshan into a new high ground for the development of the biopharmaceutical industryin May this year, Cangshan held the second quarter of key investment projects - biomedicine special signing ceremonyCangshan planning 10 projects in the biopharmaceutical industry, the total investment is expected to reach 11.5 billion yuanAmong them, Fujian Precision and Regenerative Medicine Engineering Research Center, Fujian Huayin Diagnostic Services and Clinical Large Data Center Project, Fujian Shengchang Cell Engineering and Immunotherapy Center, Fujian Tongchun Jinshan Logistics Center, Foo Biopharmaceutical Industrial Park, antithrombotic drug research and development and industrialization and other 6 key projects participated in the signing ceremonyat present, Cangshan is implementing the "five ones" action for the development of the biopharmaceutical industry to accelerate the development of the biopharmaceutical industry At the same time, Cangshan has also set up a leading group for the promotion of the biopharmaceutical industry, set up a group of experts on biopharmaceutical industry composed of relevant professional doctors from Peking University, and set about the formation of a biopharmaceutical industry alliance composed of representatives of scientific research institutions, venture capital institutions, biopharmaceutical enterprises and other quartet it is understood that Cangshan will focus on new drug research and development, in vitro diagnosis, high-end medical equipment, brand chinese medicine, Internet and medical care, such as the five key development direction, to do a large biopharmaceutical industry scale The development goal of reaching 20 billion yuan by the end of 2021 and 50 billion yuan by 2025 has been planned for the region's biopharmaceutical industry.